Cyclooxygenase 3D structures
From Proteopedia
(Difference between revisions)
(New page: == 3D Structures of cyclooxygenase == Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} {{#tree:id=OrganizedByTopic|openlevels=0| *COX I or prostaglandin H2 sy...) |
|||
| (2 intermediate revisions not shown.) | |||
| Line 6: | Line 6: | ||
*COX I or prostaglandin H2 synthase I or prostaglandin G/H synthase I | *COX I or prostaglandin H2 synthase I or prostaglandin G/H synthase I | ||
| + | **[[6y3c]] - hCOX I - human<br /> | ||
**[[3n8v]], [[1prh]] - sCOX I – sheep<br /> | **[[3n8v]], [[1prh]] - sCOX I – sheep<br /> | ||
**[[1pth]] – sCOX I + aspirin<br /> | **[[1pth]] – sCOX I + aspirin<br /> | ||
| Line 16: | Line 17: | ||
**[[3n8x]], [[3n8z]], [[1eqg]], [[5wbe]] - sCOX I + anti-inflammatory drug<br /> | **[[3n8x]], [[3n8z]], [[1eqg]], [[5wbe]] - sCOX I + anti-inflammatory drug<br /> | ||
**[[3n8y]] - sCOX I + aspirin + anti-inflammatory drug<br /> | **[[3n8y]] - sCOX I + aspirin + anti-inflammatory drug<br /> | ||
| - | **[[2oye]], [[2oyu]], [[1ebv]], [[1eqh]], [[1ht5]], [[1ht8]], [[1q4g]], [[5u6x]] - sCOX I + inhibitor<br /> | + | **[[2oye]], [[2oyu]], [[1ebv]], [[1eqh]], [[1ht5]], [[1ht8]], [[1q4g]], [[5u6x]], [[7jxt]] - sCOX I + inhibitor<br /> |
**[[1diy]], [[1fe2]] – sCOX I + arachidonic acid<br /> | **[[1diy]], [[1fe2]] – sCOX I + arachidonic acid<br /> | ||
*COX II or prostaglandin H2 synthase II or prostaglandin G/H synthase II | *COX II or prostaglandin H2 synthase II or prostaglandin G/H synthase II | ||
| - | **[[5f19]] - hCOX II | + | **[[5f19]] - hCOX II<br /> |
**[[5f1a]] – hCOX II (mutant) + salicylate<br /> | **[[5f1a]] – hCOX II (mutant) + salicylate<br /> | ||
**[[5ikq]], [[5ikr]], [[5ikt]], [[5ikv]], [[5kir]] - hCOX II + anti-inflammatory drug<br /> | **[[5ikq]], [[5ikr]], [[5ikt]], [[5ikv]], [[5kir]] - hCOX II + anti-inflammatory drug<br /> | ||
| Line 33: | Line 34: | ||
**[[3hs5]], [[3hs6]], [[3hs7]], [[3krk]], [[3mdl]], [[3olt]], [[3olu]], [[3qh0]] - mCOX II (mutant) + fatty acid substrate<br /> | **[[3hs5]], [[3hs6]], [[3hs7]], [[3krk]], [[3mdl]], [[3olt]], [[3olu]], [[3qh0]] - mCOX II (mutant) + fatty acid substrate<br /> | ||
**[[3ln0]], [[3mqe]], [[3ntg]] - mCOX II + benzopyran inhibitor<br /> | **[[3ln0]], [[3mqe]], [[3ntg]] - mCOX II + benzopyran inhibitor<br /> | ||
| + | **[[6v3r]] – mCOX II + harmaline analog<br /> | ||
**[[4rut]] – mCOX II + arachidonic acid<br /> | **[[4rut]] – mCOX II + arachidonic acid<br /> | ||
| + | **[[6ofy]] – mCOX II (mutant) + arachidonic acid<br /> | ||
**[[1cvu]] – mCOX II + peptide + arachidonic acid<br /> | **[[1cvu]] – mCOX II + peptide + arachidonic acid<br /> | ||
**[[1ddx]] – mCOX II + prostaglandin + arachidonic acid<br /> | **[[1ddx]] – mCOX II + prostaglandin + arachidonic acid<br /> | ||
| Line 40: | Line 43: | ||
**[[6bl3]], [[6bl4]] - mCOX II + indomethacine-dansyl conjugate<br /> | **[[6bl3]], [[6bl4]] - mCOX II + indomethacine-dansyl conjugate<br /> | ||
**[[4o1z]] - sCOX II + anti-inflammatory drug<br /> | **[[4o1z]] - sCOX II + anti-inflammatory drug<br /> | ||
| + | **[[8et0]] - mCOX II + nanobody<br /> | ||
}} | }} | ||
[[Category:Topic Page]] | [[Category:Topic Page]] | ||
Current revision
3D Structures of cyclooxygenase
Updated on 17-February-2025
